Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-22 5:17 pm Sale | 13D | STRATA SKIN SCIENCES INC SSKN | Broadfin Capital LLC | 2,170,757 6.39% | -793,423 (-26.77%) | View |
| 2020-01-15 5:11 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Broadfin Capital LLC | 2,541,222 12.9% | 606,299 (+31.33%) | View |
| 2019-12-23 5:28 pm Purchase | 13D | BIODELIVERY SCIENCES INTL INC BDSI | Broadfin Capital LLC | 6,732,911 6.8% | 809,586 (+13.67%) | View |
| 2019-11-18 5:00 pm Purchase | 13D | STRATA SKIN SCIENCES INC SSKN | Broadfin Capital LLC | 2,964,180 8.7% | 2,964,180 (New Position) | View |
| 2019-10-04 5:32 pm Unchanged | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | Broadfin Capital LLC | 3,102,673 8.3% | 0 (Unchanged) | View |
| 2019-10-04 4:18 pm Unchanged | 13D | AVADEL PHARMACEUTICALS PLC SPO AVDL | Broadfin Capital LLC | 3,102,673 8.3% | 0 (Unchanged) | View |
| 2019-07-22 4:08 pm Sale | 13G | ARATANA THERAPEUTICS INC PETX | Broadfin Capital LLC | 0 0% | -7,258,135 (Position Closed) | View |
| 2019-07-19 4:20 pm Purchase | 13G | RETROPHIN, INC. RTRX | Broadfin Capital LLC | 2,077,432 5.01% | 161,441 (+8.43%) | View |
| 2019-06-14 4:26 pm Purchase | 13G | EIGER BIOPHARMACEUTICALS INC C EIGR | Broadfin Capital LLC | 1,656,137 6.78% | 1,656,137 (New Position) | View |